menu search

Centers for medicare & medicaid services establishes new category i cpt® add-on code for coronary ivl

New Add-On Code Goes Into Effect January 1, 2024 SANTA CLARA, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pio...

November 3, 2023, 12:00 pm

Lexeo therapeutics announces pricing of initial public offering

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to transform...

November 3, 2023, 1:51 am

Biocardia to host q3 2023 corporate update and financial results conference call on november 8, 2023

SUNNYVALE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the t...

November 1, 2023, 9:04 pm

Biocardia to host q3 2023 corporate update and financial results conference call on november 8, 2023

SUNNYVALE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the tr...

November 1, 2023, 5:04 pm

Tourmaline bio: ted and ascvd targeting with differentiated il-6

Tourmaline Bio is advancing the use of its drug candidate TOUR006 for the treatment of thyroid eye disease and atherosclerotic ...

November 1, 2023, 2:09 pm

cardiol therapeutics reaches new milestone in phase ii study for recurrent pericarditis

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) announced it has successfully enrolled over 50% of the tar...

November 1, 2023, 8:41 am

Why is cardio diagnostics (cdio) stock up 45% today?

Shares of cardiovascular medicine specialist cardio Diag...

October 31, 2023, 3:56 pm

Verve and lilly relationship expands to include verve’s in vivo gene editing programs targeting pcsk9 and angptl3

Lilly Purchases Product Rights to Verve’s Lead cardiovascular Programs from Beam Therapeutics BOSTON,...

October 31, 2023, 10:01 am

No racial disparities seen in long-term mace for women with cad

For women with obstructive coronary artery disease (CAD), there are no racial and ethnic disparities in long-term major adverse ...

October 31, 2023, 7:14 am

Kento health raises $4.1 million cad to bring ai to cardiovascular care

Montréal-based healthtech startup Kento Health has closed an $4.1-million CAD ($3-million USD) pre-seed financing round. Read Full Story at source (m...

October 30, 2023, 7:14 pm

Medtronic stock is simply too cheap to ignore

Medtronic is a global medical technology company specializing in various medical devices. The company's revenues are well distributed among different ...

October 29, 2023, 5:07 am

Merit medical (mmsi) q3 earnings top estimates, fy23 view revised

Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its cardi...

October 27, 2023, 12:47 pm

Shockwave medical announces details for conference call discussing third quarter 2023 results and participation in upcoming investor conference

SANTA CLARA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of t...

October 26, 2023, 4:30 pm

Why is lianbio (lian) stock up 130% today?

Shares of LianBio (NASDAQ: LIAN ) — which focuses on “developing and commercializing medicines for cardio<...

October 24, 2023, 1:48 pm

Tourmaline bio announces closing of merger with talaris therapeutics and concurrent private placement of $75 million

Tourmaline will be focused on advancing TOUR006, its differentiated anti-IL-6 antibody, to treat thyroid eye disease (TED), atherosclerotic ...

October 19, 2023, 9:37 pm

Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of alnylam pharmaceuticals, inc.(alny)

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam Pharmaceuticals, In...

October 19, 2023, 5:13 pm

Intellia's (ntla) ind for gene-editing therapy gets fda clearance

Intellia (NTLA) gets FDA nod to begin a phase III study on its gene editing candidate, NTLA-2001 to treat transthyretin amyloidosis with ...

October 19, 2023, 12:47 pm

Arca biopharma announces third quarter 2023 financial results

Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic option...

October 18, 2023, 8:25 pm

Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of alnylam pharmaceuticals, inc.

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam Pharmaceuticals, In...

October 17, 2023, 10:06 pm

Cyclarity therapeutics announces clinical advisory board

NOVATO, Calif, Oct. 17, 2023 (GLOBE NEWSWIRE) — Cyclarity Therapeutics, Inc. (https://cyclaritytx.com), today announced its newly formed Clinical Ad...

October 17, 2023, 10:04 pm


Search within

Pages Search Results: